Company Website

Contact Information:

Ana M Gregorio
ana.gregorio@sanofi.com
845-214-3801

Ryan Bookout
ryan.bookout@sanofi.com
813-546-9837

Virtual Exhibit Hall Home

REZUROCK® (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD) after you have received at least 2 prior treatments (systemic therapy) and they did not work. It is not known if REZUROCK is safe and effective in children less than 12 years old.® (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD) after you have received at least 2 prior treatments (systemic therapy) and they did not work. It is not known if REZUROCK is safe and effective in children less than 12 years old.

About the ROCK2 pathway:

Many systems in the body work through what are called "PATHWAYS." These pathways are a series of actions that take place among cells and molecules within the body. One such pathway is called "ROCK2."

In people with chronic GVHD, this ROCK2 pathway is too active. This leads to a decrease in cells and molecules that help keep the immune system in check and an increase in cells and molecules that cause inflammation and fibrosis. The result is an immune system that is OUT OF BALANCE.

Learn more about how REZUROCK® works

Additional Information:

Rezurock Flashcard  
Rezurock Kadmon Guide for HCP Team  
Kadmon Assist Guide